{
  "type": "ref",
  "text": "Three patients developed deep vein thromboses and two heavily pretreated patients developed treatment-related acute myelogenous leukemia or myelodysplasia after 3.7 and 12 months of therapy.\n",
  "self": {
    "NER": {
      "answers": [
        "Three",
        "two",
        "3.7 and 12 months"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How many patients developed deep vein thromboses?",
          "How many patients developed treatment-related acute myelogenous leukemia?",
          "How long did the patients receive treatment for a myelogenous leukemia?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Three patients",
        "deep vein thromboses",
        "two heavily pretreated patients",
        "treatment-related acute myelogenous leukemia",
        "myelodysplasia",
        "3.7 and 12 months",
        "therapy"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How many patients developed deep vein thromboses?",
          "What did three patients develop after treatment?",
          "How many patients developed treatment-related acute myelogenous leukemia?",
          "What did two patients with pretreatment develop?",
          "What is another name for acute myelogenous leukemia?",
          "How long did the patients receive treatment for a myelogenous leukemia?",
          "What did the patients receive after 3.7 and 12 months of treatment?"
        ]
      }
    }
  },
  "asked": {
    "What percentage of patients had relapsed diffuse large B-cell lymphoma?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0048476457595825195,
        "ground_truth": {
          "63%": {
            "bertscore": 0.6323405504226685,
            "f1": 0
          }
        }
      }
    },
    "How many regimens were used to treat the patients with relapsed B-cell lymph": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0498543381690979,
        "ground_truth": {
          "three": {
            "bertscore": 0.7179229259490967,
            "f1": 0
          }
        }
      }
    },
    "What was the international prognostic index of high risk patients?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00028139352798461914,
        "ground_truth": {
          "79%": {
            "bertscore": 0.6308851838111877,
            "f1": 0
          }
        }
      }
    },
    "What percentage of patients had relapsed after autologous stem cell transplant?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005640923976898193,
        "ground_truth": {
          "34%": {
            "bertscore": 0.6208763718605042,
            "f1": 0
          }
        }
      }
    },
    "What patients had a high risk of relapsed diffuse large B-cell lympho": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.03615987300872803,
        "ground_truth": {
          "These patients": {
            "bertscore": 0.6474289894104004,
            "f1": 0
          }
        }
      }
    },
    "What type of large B-cell lymphoma was most common in the relapse": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.011319279670715332,
        "ground_truth": {
          "diffuse": {
            "bertscore": 0.7413909435272217,
            "f1": 0
          }
        }
      }
    },
    "What type of lymphoma was most commonly seen in the relapsed patients?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.1788223385810852,
        "ground_truth": {
          "large B-cell lymphoma": {
            "bertscore": 0.6360318660736084,
            "f1": 0
          }
        }
      }
    },
    "What was the mean of three regimens?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0026599764823913574,
        "ground_truth": {
          "median": {
            "bertscore": 0.6915010809898376,
            "f1": 0
          }
        }
      }
    },
    "What was the risk factor for relapsed diffuse large B-cell lymphoma": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00922703742980957,
        "ground_truth": {
          "high risk": {
            "bertscore": 0.7347464561462402,
            "f1": 0
          },
          "79% international prognostic index": {
            "bertscore": 0.6289376020431519,
            "f1": 0
          }
        }
      }
    },
    "What treatment did 34% of patients receive?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0011574029922485352,
        "ground_truth": {
          "autologous stem cell transplant": {
            "bertscore": 0.6722856760025024,
            "f1": 0
          }
        }
      }
    }
  }
}